Jayson Donald Alexander Dallas's Net Worth
$6.02 Million
Who is Jayson Donald Alexander Dallas?
Jayson Donald Alexander Dallas has an estimated net worth of $6.02 Million. This is based on reported shares across multiple companies, which include ARENA PHARMACEUTICALS INC, Ultragenyx Pharmaceutical Inc., Galecto, Inc., and Aimmune Therapeutics, Inc..
SEC CIK
Jayson Donald Alexander Dallas's CIK is 0001650322
Past Insider Trading and Trends
2020 was Jayson Donald Alexander Dallas's most active year for acquiring shares with 10 total transactions. Jayson Donald Alexander Dallas's most active month to acquire stocks was the month of May. 2022 was Jayson Donald Alexander Dallas's most active year for disposing of shares, totalling 9 transactions. Jayson Donald Alexander Dallas's most active month to dispose stocks was the month of February. 2018 saw Jayson Donald Alexander Dallas paying a total of $100,586.80 for 461,631 shares, this is the most they've acquired in one year. In 2020 Jayson Donald Alexander Dallas cashed out on 892,302 shares for a total of $10,139,565.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ARENA PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.15K |
—
|
—
|
0
|
Mar 11
| |||
Form 4
| +34.74% | 1.84K |
$66.36 | -$81,158.28 | 7.15K |
Scheduled
|
Jun 11 - Jun 15
| ||
Form 4
| -20.00% | -1.33K |
$80.50 | -$106,823.50 | 5.31K |
Scheduled
|
Jan 19
| ||
Form 4
| +0.08% | 5 |
$69.31 | $346.55 | 6.63K |
Dec 11
| |||
Form 4
| +0.08% | 5 |
$66.25 | $331.24 | 6.63K |
Dec 8
| |||
Form 4
| +58.53% | 2.45K |
—
|
—
| 6.63K |
Jun 12
| |||
Form 4
| +37.02% | 1.13K |
$55.90 | -$85,240.33 | 4.18K |
Scheduled
|
Jun 13 - Jun 14
| ||
Form 4
|
∞
| 3.05K |
—
|
—
| 3.05K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Ultragenyx Pharmaceutical Inc. (RARE) Snapshot price: $55.24
EVP & Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.22% | -294.00 |
$73.73 | -$21,676.62 | 23.83K |
Jun 1
| |||
Form 4
| +6.45% | 1.43K |
—
|
—
| 23.6K |
Apr 19
| |||
Form 4
| +37.60% | 6.06K |
$48.43 | -$21,357.63 | 22.17K |
Mar 1
| |||
Form 4
| -5.51% | -940.00 |
$62.59 | -$58,834.60 | 16.11K |
Aug 3
| |||
Form 4
| -1.84% | -320.00 |
$56.61 | -$18,115.20 | 17.05K |
Jun 1
| |||
Form 4
| +36.12% | 4.5K |
—
|
—
| 16.96K |
Mar 1
| |||
Form 4
| -7.01% | -940.00 |
$64.24 | -$60,385.60 | 12.46K |
Aug 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
| +34.00% | 3.4K |
—
|
—
| 13.4K |
Jun 1
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Aug 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Galecto, Inc. (GLTO) Snapshot price: $11.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Aimmune Therapeutics, Inc. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -119.67K |
$34.50 | -$4,128,684.00 |
0
|
Oct 10 - Oct 13
| |||
Form 4
| -1.38% | -1.64K |
$34.25 | -$56,238.50 | 117.03K |
Sep 15
| |||
Form 4
| -6.25% | -7.91K |
$18.02 | -$142,484.14 | 118.68K |
Jun 22
| |||
Form 4
| +2.68% | 3.3K |
—
|
—
| 126.58K |
May 10
| |||
Form 4
| +2.21% | 2.67K |
$18.74 | $49,934.11 | 123.28K |
Mar 10
| |||
Form 4
| -2.49% | -3.08K |
$23.81 | -$73,358.61 | 120.62K |
Mar 2
| |||
Form 4
| +36.38% | 33K |
—
|
—
| 123.7K |
Feb 28
| |||
Form 4
| +54.99% | 35K |
—
|
—
| 98.65K |
Feb 22
| |||
Form 4
| +6.08% | 3.65K |
$27.56 | $100,586.80 | 63.65K |
Nov 19
| |||
Form 4
|
∞
| 60K |
—
|
—
| 60K |
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |